FREAMINE II 8.5% Drug Patent Profile
✉ Email this page to a colleague
When do Freamine Ii 8.5% patents expire, and what generic alternatives are available?
Freamine Ii 8.5% is a drug marketed by B Braun and is included in one NDA.
The generic ingredient in FREAMINE II 8.5% is amino acids. There are three hundred and fifty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the amino acids profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Freamine Ii 8.5%
A generic version of FREAMINE II 8.5% was approved as amino acids by B BRAUN on April 13th, 2012.
Summary for FREAMINE II 8.5%
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | FREAMINE II 8.5% at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for FREAMINE II 8.5%
US Patents and Regulatory Information for FREAMINE II 8.5%
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B Braun | FREAMINE II 8.5% | amino acids | INJECTABLE;INJECTION | 016822-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |